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Abstract
Background—Evidence in animal models and humans suggests that exposure to polycyclic 
aromatic hydrocarbons (PAHs) may lead to birth defects. To our knowledge, this relationship has 
not been evaluated for craniosynostosis, a birth defect characterized by the premature closure of 
sutures in the skull. We conducted a case-control study to examine associations between maternal 
occupational exposure to PAHs and craniosynostosis.
Methods—We used data from craniosynostosis cases and control infants in the National Birth 
Defects Prevention Study (NBDPS) with estimated delivery dates from 1997–2002. Industrial 
hygienists reviewed occupational data from the computer-assisted telephone interview and 
assigned a yes/no rating of probable occupational PAH exposure for each job from one month 
before conception through delivery. We used logistic regression to assess the association between 
occupational exposure to PAHs and craniosynostosis.
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Results—The prevalence of exposure was 5.3% in case mothers (16/300) and 3.7% in control 
mothers (107/2,886). We observed a positive association between exposure to PAHs during the 
one month before conception through the third month of pregnancy and craniosynostosis [odds 
ratio (OR) = 1.75; 95% confidence interval (CI): 1.01, 3.05] after adjusting for maternal age and 
maternal education. The number of cases for each craniosynostosis subtype limited subtype 
analyses to sagittal craniosynostosis; the odds ratio remained similar (OR = 1.76, 95% CI: 0.82–
3.75), but was not significant.
Conclusions—Our findings support a moderate association between maternal occupational 
exposure to PAHs and craniosynostosis. Additional work is needed to better characterize 
susceptibility and the role PAHs may play on specific craniosynostosis subtypes.
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INTRODUCTION
Polycyclic aromatic hydrocarbons (PAHs) are a group of toxic chemicals that are ubiquitous 
in certain occupational settings, including the oil and gas industry, coal-fired and other 
power plants, and restaurants (Sjaastad & Svendsen, 2009). These toxicants have been 
linked to adverse birth outcomes such as intrauterine growth retardation (Choi, Rauh, 
Garfinkel, Tu, & Perera, 2008), preterm birth (Singh et al., 2008), decreased infant growth 
(Choi et al., 2006; Langlois et al., 2014), as well as certain birth defects (e.g., gastroschisis 
(Lupo, Langlois, et al., 2012), oral clefts (Langlois et al., 2013), and neural tube defects 
(Ren et al., 2011)). However, no studies have examined the relationship between PAHs and 
craniosynostosis, a condition characterized by the premature closure of one or more of the 
sutures in the infant skull (Nagaraja, Anslow, & Winter, 2013). This relationship is of 
particular interest as previous assessments suggest craniosynostosis is associated with 
maternal smoking (Hackshaw, Rodeck, & Boniface, 2011), a major source of environmental 
PAHs.
Given the growing evidence of the teratogenic potential of PAHs, and the need to better 
understand modifiable risk factors for craniosynostosis— especially with well-designed, 
large-scale population-based studies— we investigated associations between maternal 
occupational exposure to PAHs and risk of craniosynostosis among offspring using data 
from the National Birth Defects Prevention Study (NBDPS).
MATERIALS AND METHODS
The study population included craniosynostosis case and control infants from the NBDPS, 
with estimated delivery dates from October 1, 1997 through December 31, 2002. Details of 
the NBDPS have been published previously (Yoon et al., 2001). Briefly, the NBDPS is a 
multi-center, population-based, case-control study of major birth defects. During the period 
1997–2002, case infants with one or more major birth defects were identified through eight 
birth defect surveillance systems in the United States (Arkansas, California, Georgia, Iowa, 
Massachusetts, New Jersey, New York, and Texas). The cases identified included live 
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births, stillbirths, and induced pregnancy terminations. Clinical geneticists used standardized 
case definitions and confirmatory diagnostic procedures (Rasmussen et al., 2003) to classify 
case infants. Infants and fetuses with single gene disorders or chromosomal abnormalities 
were excluded, and each eligible case was classified as having an isolated defect (no 
additional major birth defect) or multiple defects (one or more additional unrelated major 
birth defects). The sutures involved were also identified (i.e., sagittal, coronal, metopic, 
lambdoid, multiple sutures, or unknown). Control infants (live born infants without major 
birth defects) were randomly selected from birth certificates or birth hospital records from 
the same geographic populations that gave rise to the cases.
Case and control mothers completed a 1-hour computer-assisted telephone interview (CATI) 
between six weeks and two years after the estimated date of delivery. The interview 
included sections on maternal health, lifestyle and behavioral characteristics, and 
occupational history. For each job, mothers were asked to describe: job title, typical job 
tasks, employer, what their employer made or did, any specific equipment or chemicals 
used, typical hours per week worked, and starting and stopping dates. Jobs were classified 
according to the Standard Occupational Classification (SOC) System (United States 
Department of Labor Bureau of Labor Statistics, 2000) and the North American Industry 
Classification System (United States Department of Labor Bureau of Labor Statistics, 1997). 
Two trained industrial hygienists, working independently and blinded to case-control status, 
reviewed job descriptions from the CATI and assigned a dichotomous (yes/no) rating of 
probable occupational PAH exposure for each job. Any discrepancies were resolved in a 
consensus meeting, which included a third hygienist. The approach used to estimate PAH 
exposure has been described previously (Rocheleau et al., 2011) and is described in detail in 
other NBDPS studies (Langlois et al., 2014; Langlois et al., 2013; Langlois et al., 2012; 
Lupo, Langlois, et al., 2012; Lupo, Symanski, et al., 2012).
Prior to the interview, all mothers provided verbal consent for study participation. The 
Centers for Disease Control and Prevention Institutional Review Board (IRB), along with 
the IRBs for each participating center, approved the NBDPS.
Our analysis was limited to case infants with a diagnosis of craniosynostosis and all control 
infants with exposure information. Specifically, case and control mothers were eligible if 
they worked in part-time or full-time jobs (paid or volunteer) for at least 1 month from the 3 
months before conception through the end month of pregnancy. Of the 4,584 eligible 
mothers with estimated delivery dates between 1997–2002, 1,275 (28%) were excluded 
from the analysis because they did not work during this time period. For our primary 
analysis, a mother was classified as exposed if she had one or more jobs rated as exposed 
during the critical period defined as one month before conception through the third month of 
pregnancy, and was classified as unexposed if all of her jobs during this time period were 
rated as unexposed. Although the critical period for exposure is likely in early pregnancy, 
we conducted a secondary analysis where the exposure window was defined as one month 
before conception through delivery, because suture closure is not completed until after birth.
Information about maternal demographic and infant characteristics was obtained from the 
CATI, and included maternal age at delivery (<20, 20–24, 25–29, 30–34, ≥35 years); pre-
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pregnancy body mass index (BMI, kg/m2) (<18.5, 18.5–24.9, 25–29.9, ≥30); parity (0, ≥1); 
maternal race or ethnicity (non-Hispanic white, Non-Hispanic black, Hispanic, Other); 
maternal education (<12, 12, >12 years); gestational diabetes (yes/no); alcohol use one 
month before pregnancy through the third month of pregnancy (yes/no); smoking history 
one month before pregnancy through the third month of pregnancy (nonsmoker, light 
moderate, heavy); secondhand smoke at home (yes/no); secondhand smoke at work (yes/no), 
and infant sex (male/female). We calculated frequency distributions of these maternal 
demographics for cases and controls, and the crude odds ratios and 95% CIs for the 
associations between each maternal factor and craniosynostosis.
To examine the association between exposure to PAHs in the workplace and 
craniosynostosis, we used unconditional logistic regression models to calculate crude and 
multivariable- adjusted odds ratios (ORs) and 95% confidence intervals (CIs). The variables 
considered for our final model were determined a priori based on a review of the 
craniosynostosis literature, and all variables were established or suspected risk factors for 
craniosynostosis (maternal age, maternal education, race/ethnicity, smoking history, 
exposure to secondhand smoke at home, and body mass index) (Boulet, Rasmussen, & 
Honein, 2008; Carmichael et al., 2008; Lee et al., 2012). Variables were incorporated as 
confounders in the final model if inclusion resulted in ≥10% change in the estimate of the 
effect between PAHs and craniosynostosis. Due to the numbers of cases for each 
craniosynostosis subtype, we were only able to estimate a separate multiple logistic 
regression model for sagittal craniosynostosis.
RESULTS
The study population included 316 craniosynostosis cases and 2,993 control infants, with 
delivery dates from October 1, 1997 through December 31, 2002. Maternal occupational 
exposure to PAHs was 5.3% among case mothers and 3.7% among control mothers during 
the month before conception through the third month of pregnancy. Mothers of case infants 
were older (mean age case mothers = 30.0 years; mean age control mothers = 28.2 years) 
and more likely to be exposed to secondhand smoke at home (Table 1). Case infants were 
more likely to be males.
In the unadjusted analysis (Table 2), maternal occupational exposure to PAHs during the 
one month before conception through the third month of pregnancy was positively, but not 
significantly, associated with craniosynostosis (OR = 1.44, 95% CI: 0.84, 2.47). However, in 
the final model, adjusted for maternal age and education, mothers of cases were 75% (95% 
CI: 1.01, 3.05) more likely to be exposed to occupational PAHs when compared to control 
mothers. In the fully adjusted model where exposure was defined as one month before 
conception through delivery, the effect was attenuated (OR = 1.55, 95% CI: 0.91, 2.70).
Our analyses of specific craniosynostosis subtypes were limited by sample size [sagittal: 163 
cases (52%); metopic: 50 cases (16%); coronal: 57 cases (18%); lambdoid: 15 cases (5%); 
multiple types: 28 cases (9%); unspecified: 3 cases (1%) ]. Therefore, we only analyzed the 
largest subtype (i.e., sagittal). Specifically, the OR from the multivariable-adjusted model 
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for sagittal craniosynostosis suggested increased risk, but it was not statistically significant 
(OR = 1.76, 95% CI: 0.82, 3.75).
DISCUSSION
Using data from the largest population-based case-control study of birth defects in the 
United States, we observed a modest association between maternal occupational exposure to 
PAHs during the early months of pregnancy and risk of craniosynostosis among offspring. 
Our findings are in keeping with a growing body of literature suggesting the teratogenic 
potential of PAHs (Ren et al., 2011).
While there have been no previous assessments of maternal occupational exposure to PAHs 
and craniosynostosis, these toxicants have been linked to birth defects in other 
epidemiologic research. For example, studies have reported associations between PAHs and 
gastroschisis (Lupo, Langlois, et al., 2012), small for gestational age (Langlois et al., 2014), 
and neural tube defects (Ren et al., 2011). There is also biological evidence that PAHs may 
be teratogenic. PAHs are lipophilic and readily absorbed by human tissue, including the 
placenta (Agency for Toxic Substances and Disease Registry, 1995). Once inhaled or 
ingested, they are metabolized into compounds capable of binding to DNA. These PAH-
DNA adducts can trigger cellular mutations that are teratogenic (Wells, McCallum, Lam, 
Henderson, & Ondovcik, 2010). Furthermore, PAH-DNA adducts have been detected in 
fetal organs, umbilical cord blood, and amniotic fluid (Agency for Toxic Substances and 
Disease Registry, 1995). Finally, birth defects and other adverse fetal outcomes have been 
reported in animal models after maternal exposure to PAHs (Barbieri, Ognio, Rossi, 
Astigiano, & Rossi, 1986; Incardona, Collier, & Scholz, 2004; Lambert & Nebert, 1977).
Our findings must be considered in light of certain limitations. There is the potential for 
exposure misclassification when using expert assessments of job descriptions, although this 
method is generally considered superior to self-reported exposures that depend on 
participant awareness of PAH exposures and accurate recall. Furthermore, assessing 
occupational exposure to PAHs, even if captured without any exposure misclassification, is 
not a complete assessment of exposure, given how ubiquitous PAHs are in the environment, 
and we lacked additional information on other potential environmental sources. That said, 
occupational exposure to PAHs often exceeds the level of exposure in the environment 
(Brandt & Watson, 2003). We did not have information on the intensity and frequency of 
exposure, which prevented an analysis of between- and within- job exposure variability, as 
well as an exposure-response analysis.
Because this is an observational study, uncontrolled or residual confounding could explain 
the relation between exposure to PAHs and craniosynostosis. However, detailed information 
on the health and lifestyle of the participants permitted evaluation of many potential 
confounders. We did not observe any change to our conclusions when smoking (or exposure 
to secondhand smoke) was considered in our models. The sample size limited this and other 
stratified and subtype analyses. For example, we were only able to evaluate associations 
among sagittal craniosynostosis. Larger sample sizes are needed to examine the effects of 
PAHs on other craniosynostosis subtypes.
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Strengths of our study include the use of data from the NBDPS, the largest population-based 
case-control study of birth defects, which has extensive occupational PAH exposure 
information from 1997–2002, as well as detailed information on potential confounders. 
Furthermore, the thorough case classification process in the NBDPS by clinical geneticists 
excluded cases due to single gene disorders or chromosomal abnormalities, resulting in a 
more homogeneous craniosynostosis case group.
CONCLUSIONS
To our knowledge, this is the first study to assess maternal occupational exposure to PAHs 
and craniosynostosis in offspring. Our analysis suggests that PAH exposure during early 
pregnancy is associated with a moderately increased risk of craniosynostosis in offspring. 
Because PAHs are ubiquitous in our environment, it is important to consider their effects on 
human health, and increase awareness of potential harm so that those at greatest risk may 
employ measures to minimize exposure, especially during pregnancy. Future investigations 
could be improved by incorporating additional measures of exposure and the inclusion of 
additional cases for a closer examination of PAHs and craniosynostosis subtype.
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Table 1
Distribution of maternal factors among employeda mothers of craniosynostosis case infants and control 











 Male 223 (71) 1,495 (50) 2.40 (1.86, 3.09)
 Female 93 (29) 1,496 (50) 1.00 (Ref)
Maternal
Age (years)
 <20 14 (4) 240 (8) 1.00 (Ref)
 20–24 56 (18) 645 (22) 1.49 (0.81, 2.72)
 25–29 67 (21) 801 (27) 1.43 (0.79, 2.60)
 30–34 104 (33) 858 (29) 2.08 (1.17, 3.70)
 ≥35 75 (24) 449 (15) 2.86 (1.58, 5.17)
Prepregnancy BMI (kg/m2)
 Underweight (<18.5) 16 (5) 153 (5) 1.02 (0.59, 1.75)
 Normal weight (18.5–24.9) 172 (55) 1,676 (57) 1.00 (Ref)
 Overweight (25–29.9) 73 (23) 664 (23) 1.07 (0.80, 1.43)
 Obese (≥30) 53 (17) 439 (15) 1.18 (0.85, 1.63)
Parity
 0 139 (44) 1,331 (44) 1.00 (Ref)
 ≥1 177 (56) 1,661 (56) 1.02 (0.81, 1.29)
Race/ethnicity
 Non-Hispanic white 242 (77) 1,940 (65) 1.00 (Ref)
 Non-Hispanic black 14 (4) 377 (13) 0.30 (0.17, 0.52)
 Hispanic 45 (14) 528 (18) 0.68 (0.49, 0.95)
 Other 15 (5) 141 (5) 0.85 (0.49, 1.48)
Education (years)
 <12 21 (7) 296 (10) 1.00 (Ref)
 12 73 (23) 741 (25) 1.39 (0.84, 2.30)
 >12 221 (70) 1,951 (65) 1.60 (1.00, 2.54)
Gestational diabetes
 No 288 (95) 2,804 (96) 1.00 (Ref)
 Yes 16 (5) 118 (4) 1.32 (0.77, 2.26)
Smokingb
 Nonsmoker 243 (77) 2,378 (79) 1.00 (Ref)
 Light (15–24 cigarettes/day) 50 (16) 423 (14) 1.15 (0.84, 1.60)
 Moderate (15–24 cigarettes/day) 21 (7) 159 (5) 1.29 (0.80, 2.08)
 Heavy (≥25 cigarettes/day) 2 (0.6) 33 (1) 0.59 (0.14, 2.29)
Secondhand smoke at homeb






















 No 245 (78) 2,456 (82) 1.00 (Ref)
 Yes 71 (22) 535 (18) 1.33 (1.01, 1.76)
Secondhand smoke at workb
 No 262 (83) 2,412 (81) 1.00 (Ref)
 Yes 54 (17) 572 (19) 0.87 (0.64, 1.18)
BMI=body mass index; CI=confidence interval; OR=odds ratio
a
Employed for at least one month from the three months before conception through the end of pregnancy.
b
One month before conception through the third month of pregnancy.
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